Arrowpoint Investment Partners »

Esperion Therapeutics shares owned by Arrowpoint Investment Partners

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Arrowpoint Investment Partners from 13F filings

Historical chart of Arrowpoint Investment Partners investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Arrowpoint Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Arrowpoint Investment Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $107k 41k 2.65

More positions owned by Arrowpoint Investment Partners

Aegon Amer Reg 1 Cert (AEG)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Select Sector Spdr Tr Sbi Healthcare Call Option (XLV)
Hallador Energy (HNRG)
Echostar Corp Cl A (SATS)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Astera Labs (ALAB)
Atour Lifestyle Hldgs Sponsored Ads (ATAT)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Bristol Myers Squibb Call Option (BMY)
Merck & Co Call Option (MRK)
Pfizer Call Option (PFE)
Abbvie Call Option (ABBV)
Hesai Group Sponsored Ads (HSAI)
Comfort Systems USA (FIX)

View all positions for Arrowpoint Investment Partners

Top funds holding Esperion Therapeutics

BlackRock
Vanguard Group
Two Seas Capital
Daniel D. Thurber
PenderFund Capital Management
Geode Capital Management
State Street Corporation
Nuveen
AIGH Capital Management
Marshall Wace
Royce & Associates
Two Sigma Investments
Jane Street
Citadel Advisors
Two Sigma Advisers

View all funds holding Esperion Therapeutics